SI-10   Click here for help

GtoPdb Ligand ID: 13308

Synonyms: compound 6p [PMID: 38551814]
Compound class: Synthetic organic
Comment: SI-10 is a small molecule that is designed to inhibit the oncogenic actions of nuclear receptor coactivator 3 (NCOA3; SRC3) [1]. Direct interaction between SI-10 and NCOA3 was determined in an estrogen receptor (ER) binding element (ERE) pull-down assay, and the NCOA3-dependency of its antiproliferative effect was demonstrated using lentivirus-mediated shRNA knock-down. SI-10 functions by disrupting recruitment of NCOA3 to the steroid receptor transcriptional complex, to ultimately reduce steroid receptor-regulated gene transcription in relevant tumours.
2D Structure
Click here for help

2D Structure

An image of the ligand's 2D structure. For small molecules with SMILES these are drawn using the NCI/CADD Chemical Identifier Resolver. Click on the image to access the chemical structure search tool with the ligand pre-loaded in the structure editor. For other types of ligands, e.g. longer nucleotides and peptides, a manually drawn representation of the molecule may be provided.

✖
Click here for structure editor
Physico-chemical Properties
Click here for help

Physico-chemical Properties

Calculated molecular properties are available for small molecules and natural products (not peptides). Properties were generated using the Chemistry Development Kit (CDK) (Willighagen EL et al. Journal of Cheminformatics vol. 9:33. 2017, doi:10.1186/s13321-017-0220-4; https://cdk.github.io/). All properties were selected to enable the prediction of the Lipinski Rule-of-Five profile or ‘druglikeness’ for each ligand. For more info on each category see the help pages.

✖
Hydrogen bond acceptors 6
Hydrogen bond donors 1
Rotatable bonds 2
Topological polar surface area 64.71
Molecular weight 302.28
XLogP 2.33
No. Lipinski's rules broken 0

Generated using the Chemistry Development Kit (CDK) (Willighagen EL et al. Journal of Cheminformatics vol. 9:33. 2017, doi:10.1186/s13321-017-0220-4; https://cdk.github.io/)
SMILES / InChI / InChIKey
Click here for help

SMILES / InChI / InChIKey

SMILES (Simplified Molecular Input Line Entry Specification) A specification for unambiguously describing the structure of chemical molecules using short ASCII strings. Canonical SMILES specify a unique representation of the 2D structure without chiral or isotopic specifications. Isomeric SMILES include chiral specification and isotopes.

Standard InChI (IUPAC International Chemical Identifier) and InChIKey InChI is a non-proprietary, standard, textual identifier for chemical substances designed to facilitate linking of information and database searching. An InChIKey is a simplified version of a full InChI, designed for easier web searching.

Generated using the Chemistry Development Kit (CDK) (Willighagen EL et al. Journal of Cheminformatics vol. 9:33. 2017, doi:10.1186/s13321-017-0220-4; https://cdk.github.io/)

✖
Canonical SMILES C/C(=N\N=C\1/NC2=CC(=C(C=C2N1C)F)F)/C3=NC=CC=N3
Isomeric SMILES C/C(/C1=NC=CC=N1)=N\N=C/2\N(C)C=3C=C(F)C(F)=CC3N2
InChI InChI=1S/C14H12F2N6/c1-8(13-17-4-3-5-18-13)20-21-14-19-11-6-9(15)10(16)7-12(11)22(14)2/h3-7H,1-2H3,(H,19,21)/b20-8+
InChI Key ZACMILMSJGPVPZ-DNTJNYDQSA-N

Generated using the Chemistry Development Kit (CDK) (Willighagen EL et al. Journal of Cheminformatics vol. 9:33. 2017, doi:10.1186/s13321-017-0220-4; https://cdk.github.io/)
Bioactivity Comments
SI-10 inhibits proliferation breast cancer and prostate cancer cells in vitro [1]. In vivo antitumour activity of orally administered SI-10 has been demonstrated in prostate and pancreatic cancer xenograft models. The compound has favourable pharmacokinetic, off-target and toxicity profiles; hERG inhibition is >30 μM, half-life is ~9 hours in mice (orally delivered).
Selectivity at enzymes
Key to terms and symbols Click column headers to sort
Target Sp. Type Action Value Parameter Concentration range (M) Reference
nuclear receptor coactivator 3 Hs Inhibitor Inhibition - - - 1
⤷ [1]